PURA BREAKOUT ALERT - Just Broke $0.07 200 MA On VOL w/$0.25 Analyst Target
September 20, 2019 -- InvestorsHub NewsWire -- via www.nextbigticker.com
- Major PR Campaign Next Week
- PPS Potential From $0.07 to $0.25 or Higher
- New Sales To Be Reported Next Week
- New Products To Be Introduced Next Week
Puration, Inc. (USOTC: PURA) is breaking out on high trading volume. The stock started trending VERY BULLISH yesterday as reported by StockTA (stockta.com/PURA). Goldman Small Cap Research on Wednesday this week published CBD Beverage Industry Survey results in conjunction with PURA’s latest CBD Beverage marketing initiative. Goldman’s results were accompanied by a confirmation of an earlier Analyst Research Speculative BUY Recommendation and $0.25 PPS Target Price. Today, the company launched a European Marketing Campaign at the Arnold Schwarzenegger’s Arnold Sports Festival in Barcelona, Spain.
PURA Poised Form Major PPS Jump Next Week From $0.07 To $0.25 Or Higher
PURA is poised to make a major jump. Next week could be when PURA makes that jump. The company published news today and yesterday indicating a series of corporate announcements were coming next week. After keeping their head down this past summer and expanding their beverage production capacity, the company has now recently announced a new marketing program to expand sales in Europe and indicates even more sales announcements coming next week. This company has a 52-week high of $0.25 and has made multiple double and triple bagger runs in the past and even a few runs bigger than that. PURA continues to deliver big ROI’s and looks like it will continue to do so. Again, next one could be the first one following the summer OTC market slow period.
PURA has reported over $1 million in sales for the first six months of 2019 after reporting $1 million in sales for all of 2018. The company has target selling $4 million in CBD infused beverages this year.
PURA’s EVERx CBD Sports Water utilizes Kali-Extracts’ (USOTC: KALY) U.S. Patented Cannabis Extraction Process. PURA holds the only license of the Patent for use in a beverage. KALY has recently made news with the filing of a new Patent for a cannabis extract to treat COPD. PURA may have benefited from recent KALY news.
PURA’s EVERx CBD Sports Water is available for sale online through the website www.USMJ.com from North American Cannabis Holdings, Inc. (USOTC: USMJ).
PURA news from the Arnold Sports Festival in Europe is hitting wires now. The company has announced the rollout of its European marketing program launching at the Arnold in Barcelona which started today.
NextBigTicker.com (NBT)is a third party publisher and news dissemination service provider. NBT is NOT affiliated in any manner with any company mentioned herein. NBT is news dissemination solutions provider and are NOT a registered broker/dealer/analyst/adviser, holds no investment licenses and may NOT sell, offer to sell or offer to buy any security. NBT's market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities. The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material. All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks. All material included herein is republished content and details which were previously disseminated by the companies mentioned in this release or opinion of the writer. NBT is not liable for any investment decisions by its readers or subscribers. Investors are cautioned that they may lose all or a portion of their investment when investing in stocks. NBT has not been compensated for this release and HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.
This news release contains forward-looking statements within the meaning of the Securities Litigation Reform Act. The statements reflect the Company's current views with respect to future events that involve risks and uncertainties. Among others, these risks include the expectation that any of the companies mentioned herein will achieve significant sales, the failure to meet schedule or performance requirements of the companies' contracts, the companies' liquidity position, the companies' ability to obtain new contracts, the emergence of competitors with greater financial resources and the impact of competitive pricing. In the light of these uncertainties, the forward-looking events referred to in this release might not occur.